The following is a summary of “A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland,” published in the April ...

No. GMP-MBS001). Activation was assessed by measuring the expression of CD25 and CD69 on the T cell surface using PE-labeled anti-human CD25 antibody and FITC-labeled anti-human CD69 antibody ...